Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
24507 | 309 | 37.2 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
14 | 4 | ORTHOPEDICS//DENTISTRY, ORAL SURGERY & MEDICINE//SPORT SCIENCES | 808941 |
444 | 3 | CARPAL TUNNEL SYNDROME//MEDIAN NERVE//ALDOSE REDUCTASE | 26401 |
2198 | 2 | ALDOSE REDUCTASE//ALDOSE REDUCTASE INHIBITOR//DIABETIC NEUROPATHY | 4878 |
24507 | 1 | C PEPTIDE//PROINSULIN C PEPTIDE//SECT CLIN PHYSIOL | 309 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | C PEPTIDE | authKW | 1800082 | 40% | 15% | 124 |
2 | PROINSULIN C PEPTIDE | authKW | 1111711 | 5% | 75% | 15 |
3 | SECT CLIN PHYSIOL | address | 558679 | 7% | 27% | 21 |
4 | HUMAN C PEPTIDE | authKW | 494097 | 2% | 100% | 5 |
5 | C PEPTIDE RECEPTOR | authKW | 197639 | 1% | 100% | 2 |
6 | GPR146 | authKW | 197639 | 1% | 100% | 2 |
7 | INSULIN DISAGGREGATION | authKW | 197639 | 1% | 100% | 2 |
8 | PEPTIDE DEPOSITS | authKW | 197639 | 1% | 100% | 2 |
9 | MORRIS HOOD JR COMPREHENS DIABET | address | 177867 | 2% | 30% | 6 |
10 | CARDIOVASC NETWORK | address | 131758 | 1% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 5015 | 49% | 0% | 151 |
2 | Physiology | 189 | 9% | 0% | 29 |
3 | Medicine, Research & Experimental | 131 | 9% | 0% | 27 |
4 | Biochemistry & Molecular Biology | 80 | 17% | 0% | 54 |
5 | Biophysics | 53 | 6% | 0% | 18 |
6 | Urology & Nephrology | 52 | 5% | 0% | 14 |
7 | Peripheral Vascular Diseases | 52 | 5% | 0% | 14 |
8 | Cell Biology | 43 | 8% | 0% | 25 |
9 | Medicine, General & Internal | 11 | 5% | 0% | 14 |
10 | Cardiac & Cardiovascular System | 7 | 3% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SECT CLIN PHYSIOL | 558679 | 7% | 27% | 21 |
2 | MORRIS HOOD JR COMPREHENS DIABET | 177867 | 2% | 30% | 6 |
3 | CARDIOVASC NETWORK | 131758 | 1% | 67% | 2 |
4 | CEBIX AB | 98819 | 0% | 100% | 1 |
5 | CLIN PHYSIOL POB 60500 | 98819 | 0% | 100% | 1 |
6 | ENDOCRINE METAB INTERNAL MED | 98819 | 0% | 100% | 1 |
7 | KAROLINSKA HOSP N1 05 | 98819 | 0% | 100% | 1 |
8 | KAROLINSKA HOSP SURG SCI CLIN PHYSIOL | 98819 | 0% | 100% | 1 |
9 | MED SCICENCE | 98819 | 0% | 100% | 1 |
10 | MORRIS HOOD JR COMPREHENS DIAB | 98819 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPERIMENTAL DIABESITY RESEARCH | 131750 | 2% | 22% | 6 |
2 | EXPERIMENTAL DIABETES RESEARCH | 19998 | 3% | 3% | 8 |
3 | DIABETOLOGIA | 12980 | 11% | 0% | 33 |
4 | DIABETES-METABOLISM RESEARCH AND REVIEWS | 9906 | 4% | 1% | 12 |
5 | CELLULAR AND MOLECULAR LIFE SCIENCES | 2345 | 4% | 0% | 11 |
6 | DIABETES & METABOLISM | 2214 | 3% | 0% | 8 |
7 | DIABETES STOFFWECHSEL UND HERZ | 1565 | 1% | 1% | 2 |
8 | DIABETES | 1376 | 4% | 0% | 13 |
9 | ACTA BIOCHIMICA ET BIOPHYSICA SINICA | 897 | 2% | 0% | 5 |
10 | JAPANESE JOURNAL OF VETERINARY RESEARCH | 839 | 1% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | C PEPTIDE | 1800082 | 40% | 15% | 124 | Search C+PEPTIDE | Search C+PEPTIDE |
2 | PROINSULIN C PEPTIDE | 1111711 | 5% | 75% | 15 | Search PROINSULIN+C+PEPTIDE | Search PROINSULIN+C+PEPTIDE |
3 | HUMAN C PEPTIDE | 494097 | 2% | 100% | 5 | Search HUMAN+C+PEPTIDE | Search HUMAN+C+PEPTIDE |
4 | C PEPTIDE RECEPTOR | 197639 | 1% | 100% | 2 | Search C+PEPTIDE+RECEPTOR | Search C+PEPTIDE+RECEPTOR |
5 | GPR146 | 197639 | 1% | 100% | 2 | Search GPR146 | Search GPR146 |
6 | INSULIN DISAGGREGATION | 197639 | 1% | 100% | 2 | Search INSULIN+DISAGGREGATION | Search INSULIN+DISAGGREGATION |
7 | PEPTIDE DEPOSITS | 197639 | 1% | 100% | 2 | Search PEPTIDE+DEPOSITS | Search PEPTIDE+DEPOSITS |
8 | ALA SCAN ANALYSIS | 98819 | 0% | 100% | 1 | Search ALA+SCAN+ANALYSIS | Search ALA+SCAN+ANALYSIS |
9 | AUTONOMIC NERVOUS SYSTEM INSULIN | 98819 | 0% | 100% | 1 | Search AUTONOMIC+NERVOUS+SYSTEM+INSULIN | Search AUTONOMIC+NERVOUS+SYSTEM+INSULIN |
10 | BLOOD RETINAL BARRIER FUNCTION | 98819 | 0% | 100% | 1 | Search BLOOD+RETINAL+BARRIER+FUNCTION | Search BLOOD+RETINAL+BARRIER+FUNCTION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WAHREN, J , KALLAS, A , SIMA, AAF , (2012) THE CLINICAL POTENTIAL OF C-PEPTIDE REPLACEMENT IN TYPE 1 DIABETES.DIABETES. VOL. 61. ISSUE 4. P. 761-772 | 59 | 87% | 39 |
2 | YOSTEN, GLC , MARIC-BILKAN, C , LUPPI, P , WAHREN, J , (2014) PHYSIOLOGICAL EFFECTS AND THERAPEUTIC POTENTIAL OF PROINSULIN C-PEPTIDE.AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. VOL. 307. ISSUE 11. P. E955 -E968 | 69 | 65% | 6 |
3 | WAHREN, J , LARSSON, C , (2015) C-PEPTIDE: NEW FINDINGS AND THERAPEUTIC POSSIBILITIES.DIABETES RESEARCH AND CLINICAL PRACTICE. VOL. 107. ISSUE 3. P. 309 -319 | 49 | 80% | 9 |
4 | USAREK, M , BRYLA, J , (2012) PLEIOTROPIC ACTION OF PROINSULIN C-PEPTID.POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ. VOL. 66. ISSUE . P. 135-145 | 60 | 79% | 0 |
5 | BHATT, MP , LIM, YC , HA, KS , (2014) C-PEPTIDE REPLACEMENT THERAPY AS AN EMERGING STRATEGY FOR PREVENTING DIABETIC VASCULOPATHY.CARDIOVASCULAR RESEARCH. VOL. 104. ISSUE 2. P. 234 -244 | 69 | 58% | 6 |
6 | HILLS, CE , BRUNSKILL, NJ , (2009) CELLULAR AND PHYSIOLOGICAL EFFECTS OF C-PEPTIDE.CLINICAL SCIENCE. VOL. 116. ISSUE 7-8. P. 565-574 | 53 | 75% | 36 |
7 | WAHREN, J , KALLAS, A , (2013) C-PEPTIDE CENTER DOT NOVEL THERAPEUTIC APPROACH TO MICROVASCULAR COMPLICATIONS OF TYPE 1 DIABETES?.DIABETOLOGE. VOL. 9. ISSUE 4. P. 319-331 | 40 | 85% | 0 |
8 | LUPPI, P , CIFARELLI, V , WAHREN, J , (2011) C-PEPTIDE AND LONG-TERM COMPLICATIONS OF DIABETES.PEDIATRIC DIABETES. VOL. 12. ISSUE 3. P. 276 -292 | 58 | 55% | 16 |
9 | WAHREN, J , EKBERG, K , JORNVALL, H , (2007) C-PEPTIDE IS A BIOACTIVE PEPTIDE.DIABETOLOGIA. VOL. 50. ISSUE 3. P. 503 -509 | 37 | 84% | 76 |
10 | YOSTEN, GLC , KOLAR, GR , (2015) THE PHYSIOLOGY OF PROINSULIN C-PEPTIDE: UNANSWERED QUESTIONS AND A PROPOSED MODEL.PHYSIOLOGY. VOL. 30. ISSUE 4. P. 327 -332 | 37 | 73% | 2 |
Classes with closest relation at Level 1 |